Intensification to Injectable Therapies (GLP-1 RAs and Basal Insulin): Consensus of the American Diabetes Association and European Association for the Study of Diabetes
Even with masks on you can see theyre smiling
Emerging role of IL-10 in hypertrophic scars
The notion that GLP-1 analogues may affect feeding even when they do not enter the brain is supported by studies showing that large molecular size GLP-1 receptor agonists (albumin-conjugated GLP-1 receptor agonists), that cannot cross the blood-brain barrier can inhibit feeding in both humans and mice
Systemic adverse effects may include dizziness, drowsiness, confusion, blurred vision, nausea, vomiting, and respiratory depression
Prioritise protein at every meal Protein is the single most important dietary factor on Mounjaro